Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / C•••••• N••

PSG Equity and R••••• Capital complete acquisition of C••••••

Exit to a strategic buyerclosedannounced Jan 23, 2025closed Jan 23, 2025Fact
What happened
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
unknown
Target location
unknown
Seller kind
Sponsor
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • G••••Strategic acquirerconfirmed
    G••••, Brussels and London – PSG Equity, a growth equity firm that partners with software and technology-enabled services companies, and R••••• Capital have completed the previously announced acquisition of C•••••• N••. (“C••••••” or the “Company”), a leader in medical software solutions for the pri
  • N•••••• L••••••, Senior Partner at R••••• Capital, said: “We are immensely proud of the achievements realized over the past years in collaboration with the management team at C••••••.
Sell side
  • The transaction includes new investment from PSG Equity and re-investment from R••••• Capital, following its initial investment in C•••••• in 2020. | published on R••••• C•••••• B•••'s own news page riveancapital.com
Side not stated
  • G••••, Brussels and London – PSG Equity, a growth equity firm that partners with software and technology-enabled services companies, and R••••• Capital have completed the previously announced acquisition of C•••••• N••. (“C••••••” or the “Company”), a leader in medical software solutions for the pri
Evidence
G••••, Brussels and London – PSG Equity, a growth equity firm that partners with software and technology-enabled services companies, and R••••• Capital have completed the previously announced acquisition of C•••••• N••. (“C••••••” or the “Company”), a leader in medical software solutions for the primary care market in Belgium.
PSG Equity and R••••• Capital complete acquisition of C•••••• | Private Equity Intelligence | DFX